The overall goal of this study was to assess the level of heterogeneity of protein expression in breast cancer specimens by analyzing 35 target proteins including 15 phosphorylated proteins representing the HER2, EGFR, and uPA/PAI-1 signaling pathways relevant to breast cancer. This evidence concerns the gene ERBB2 and breast carcinoma.